Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 224,708,892 papers from all fields of science
Search
Sign In
Create Free Account
NMS60
Known as:
NMS 60
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
Organometallic Compounds
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
Evaluation of CH3-DTPA-Gd (NMS60) as a new MR contrast agent : early phase 2 study in brain tumors and dual dynamic contrast-enhanced imaging
伊藤 雅人
2007
Corpus ID: 138104365
2006
2006
Evaluation of CH3-DTPA-Gd (NMS60) as a new MR contrast agent: early phase II study in brain tumors and dual dynamic contrast-enhanced imaging.
Masato Ito
,
H. Ogino
,
+6 authors
T. Miyati
Magnetic Resonance Imaging
2006
Corpus ID: 10059819
2005
2005
A Comparison of CH3-DTPA-GD (NMS60) and GD-DTPA for Evaluation of Acute Myocardial Ischemia
H. D'Arceuil
,
H. D'Arceuil
,
+7 authors
Michael E. Moseley
The International Journal of Cardiovascular…
2005
Corpus ID: 25151501
Purpose: Our objective was to evaluate the use of a new medium weight MRI contrast agent, NMS60 (a␣synthetic oligomeric Gd…
Expand
2004
2004
A comparative evaluation of CH3-DTPA-Gd (NMS60) for contrast-enhanced magnetic resonance angiography.
R. Bammer
,
A. D. de Crespigny
,
+4 authors
M. Moseley
Magnetic Resonance Imaging
2004
Corpus ID: 19141761
2004
2004
An MRA study of vascular stenosis in a pig model using CH3-DTPA-Gd (NMS60) and Gd-DTPA.
H. D'Arceuil
,
A. D. de Crespigny
,
+6 authors
M. Moseley
Magnetic Resonance Imaging
2004
Corpus ID: 23337231
1999
1999
Dynamic contrast-enhanced MRI of Implanted VX2 tumors in rabbit muscle: comparison of Gd-DTPA and NMS60.
A. D. de Crespigny
,
D. Howard
,
+7 authors
M. Moseley
Magnetic Resonance Imaging
1999
Corpus ID: 31402416
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE